Philip Morris beats Q1 forecasts but U.S. nicotine pouch sales stumble

What happened

Philip Morris posted adjusted earnings of $1.96 per share in the first quarter, surpassing analyst expectations of $1.83. Revenue climbed 9.1% to $10.15 billion, ahead of forecasts. The company's smoke-free segment, which now represents 43% of total revenue, grew 12.4% overall. International markets were the standout, with smoke-free revenue jumping 25% and IQOS heat-not-burn devices overtaking Marlboro as the leading nicotine brand in markets where it's available. Traditional cigarette sales also increased 6.7%, supported by higher pricing despite lower volumes.

Why the stock moved

Shares rose 2.8% in premarket trading following the earnings beat and upbeat international performance. However, the gains came despite a notable concern: U.S. smoke-free shipments fell 21%, with Zyn nicotine pouch shipments dropping nearly 24% even as consumer demand increased. The company acknowledged it is investing heavily to expand Zyn's flavor offerings and competitive positioning, suggesting current supply may not be keeping pace with market appetite. The full-year earnings outlook of $8.36 to $8.51 per share aligned closely with analyst estimates, providing no major surprises.

Bigger picture

Philip Morris is navigating a transition toward smoke-free products as traditional cigarette consumption declines globally. The company's international momentum with IQOS demonstrates strong traction for alternative nicotine delivery, while the U.S. market presents a more complicated picture. The mismatch between rising Zyn demand and falling shipments points to either supply chain challenges or competitive pressure in the fast-growing nicotine pouch category. Additionally, geopolitical tensions in Iran created minor headwinds in the quarter, affecting travel retail and regional shipments, though the company does not expect prolonged disruption. The projected 5% to 7% organic revenue growth reflects cautious optimism amid these crosscurrents.

What investors watch

Investors will monitor whether Philip Morris can resolve the Zyn shipment issue and capture growing U.S. nicotine pouch demand. Progress on flavor expansion and market share in that category will be critical. International smoke-free growth, particularly IQOS adoption in new markets, remains a key indicator of the company's transformation strategy. Any updates on regulatory developments for nicotine pouches or smoke-free products in major markets could also influence the stock. Finally, watch for signs that geopolitical risks or energy cost pressures meaningfully impact margins or guidance in coming quarters.

This article was generated by Quantli AI using publicly available news sources.